Canteveros, Nelsie C.
HRN: 26-38-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2024
CEFTAZIDIME 1GM (VIAL)
12/26/2024
01/02/2025
IV
2g
Q8H
CAP, PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes